Industry News
OncoEthix Doses First Patient In Its Phase I Trial Of OTX015, A BET Bromodomain Inhibitor For The Treatment Of Hematologic Malignancies
Feb 04, 2013
OncoEthix, the Swiss-based specialist in oncology drug development, announces progress in its Phase I study of OTX015, a novel BET bromodomain inhibitor, with the first dosing of a patient... Read More
Two-Step Immunotherapy Attacks Advanced Ovarian Cancer, Penn Medicine Researchers Report
Feb 04, 2013
Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies... Read More
Two-Step Immunotherapy Attacks Advanced Ovarian Cancer, Penn Medicine Researchers Report
Feb 04, 2013
Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies... Read More
Avoid Eight Cancer Screenings, Says Consumer Reports
Feb 03, 2013
Consumer reports evaluated eleven cancer screening tests, and has found that most of us should avoid eight of them. The non-profit consumer's organization says that most preventive cancer screenings are oversold and may confuse rather than clarify. In a new report, the authors say that not all cancer screening tests are helpful. In fact, they added that some of them may be harmful... Read More
Targeting Cancer Metastasis
Feb 02, 2013
Disrupting a key interaction between two types of proteins in cells inhibits the spread of cancerous cells, providing researchers with a new pathway toward developing cancer-fighting drugs, according to new findings by Georgia State University scientists. Cell migration is essential for the spread of cancerous cells, also known as metastasis, as well as for other diseases... Read More
Medical Experts Urge Vaccine For Boys To Prevent Throat Cancer Epidemic
Feb 01, 2013
New charity Throat Cancer Foundation launched today highlights 'ticking timebomb' of HPV which affects over 3,000 people per year in the UK. HPV (Human Papillomavirus) causes 5% of cancers globally and throat cancer is the fastest growing male cancer [1]. A new charity launched today calls for the introduction of a vaccine for boys to prevent an epidemic of throat cancer... Read More
Observational Study Suggests A Role For Ferinject® (Ferric Carboxymaltose) In Optimizing The Care Of Anaemic And Iron Deficient Cancer Patients
Feb 01, 2013
On the eve of World Cancer Day, Vifor Pharma notes the publication of an observational study in routine oncological and haematological settings encompassing anaemic and iron-deficient patients with a wide variety of tumours (420 subjects, efficacy population). The study was recently published in the peer-reviewed journal Annals of Oncology... Read More
Long-Term Urinary, Sexual And Bowel Function Side Effects Tracked In Prostate Cancer
Feb 01, 2013
A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment. The study, led by first author Matthew Resnick, M.D... Read More
Protection Against UV-Induced Skin Cancer Offered By Silibinin, Found In Milk Thistle
Feb 01, 2013
A pair of University of Colorado Cancer Center studies published this month show that the milk thistle extract, silibinin, kills skin cells mutated by UVA radiation and protects against damage by UVB radiation - thus protecting against UV-induced skin cancer and photo-aging... Read More
Long-Term Urinary, Sexual And Bowel Function Side Effects Tracked In Prostate Cancer
Feb 01, 2013
A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences were no longer significant 15 years after initial treatment. The study, led by first author Matthew Resnick, M.D... Read More
Previous Page Next Page